When should lactoferrin be used instead of ferric sulfate for iron supplementation?

Ferrous Sulfate Should Be Used as First-Line Iron Supplementation Over Lactoferrin

Ferrous sulfate remains the preferred oral iron supplement for iron deficiency anemia due to its established efficacy, low cost, and strong guideline support, with no evidence that lactoferrin offers clinically meaningful advantages in real-world practice 1.

Guideline-Based Recommendation

The 2024 AGA Clinical Practice Update explicitly states that "no single formulation of oral iron has any advantages over any other. Ferrous sulfate is preferred as the least expensive iron formulation" 1. This represents the most current, authoritative guidance on oral iron supplementation and should direct clinical decision-making.

When to Consider Each Option

Use Ferrous Sulfate (Standard Approach):

• All patients as first-line therapy - most cost-effective and guideline-recommended 1
• Dose: 200 mg twice daily (or lower doses if better tolerated) 2
• Add vitamin C (250-500 mg) to enhance absorption 1, 2
• Consider once-daily or every-other-day dosing for improved tolerance 1

Lactoferrin Has NO Clear Role in Standard Practice:

Despite research suggesting potential benefits, lactoferrin should not replace ferrous sulfate because:

• Most recent high-quality trial contradicts earlier findings: A 2026 randomized controlled trial in 555 Bangladeshi women with iron deficiency anemia showed lactoferrin (both 200 mg and 400 mg doses) was inferior to ferrous sulfate, with mean hemoglobin differences of -1.2 g/dL and -1.1 g/dL respectively (P < 0.0001) 3

• Guidelines do not recommend it: Neither the 2024 AGA guidelines 1 nor the 2011 Gut guidelines 2 mention lactoferrin as a treatment option

• Cost considerations: Lactoferrin is significantly more expensive than ferrous sulfate without proven superior clinical outcomes

Critical Analysis of Conflicting Evidence

Earlier meta-analyses 4, 5, 6 suggested lactoferrin superiority, but these findings are contradicted by:

1. The most recent 2026 trial 3 - the highest quality, most recent evidence showing clear inferiority
2. Mechanistic uncertainty: While lactoferrin may reduce inflammation 7, 5, this doesn't translate to better hemoglobin outcomes in the most rigorous trial
3. Population differences: Earlier positive studies were primarily in pregnant women or children with IBD 7, 6, 8, not generalizable to all patients

Algorithm for Iron Supplementation

Step 1: Start ferrous sulfate 200 mg once or twice daily with vitamin C 1, 2

Step 2: If gastrointestinal intolerance occurs:

• Try alternate-day dosing 1
• Try lower doses 2
• Switch to other ferrous preparations (fumarate, gluconate) 2

Step 3: If oral iron fails (intolerance, non-response, malabsorption):

• Use intravenous iron, not lactoferrin 1, 2
• Preferred IV formulations: those requiring 1-2 infusions 1

Common Pitfalls to Avoid

• Don't use lactoferrin as a "better tolerated" alternative - the 2026 trial showed no advantage 3, and IV iron is the appropriate next step for oral intolerance 1
• Don't assume research findings apply universally - positive lactoferrin studies were in specific populations (pregnancy, pediatric IBD) that may not generalize 7, 6, 8
• Don't skip vitamin C supplementation - this enhances ferrous sulfate absorption 1, 2
• Don't continue ineffective oral therapy - if ferritin doesn't improve after a trial, switch to IV iron 1

Special Populations Where Evidence Remains Unclear

While some studies suggest lactoferrin benefits in:

• Pediatric IBD 7 - showed improved outcomes, but this is a highly specific population
• Pregnancy 6, 8 - earlier studies showed promise, but the 2026 trial contradicts this 3

Even in these populations, ferrous sulfate remains guideline-recommended first-line therapy 1, with IV iron as the appropriate escalation for treatment failure.